Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy.

Islet amyloid polypeptide (IAPP or amylin) is a 37-residue peptide hormone associated with glucose metabolism that is cosecreted with insulin by beta-cells in the pancreas. Since human IAPP is a highly amyloidogenic peptide, it has been suggested that the formation of IAPP amyloid fibers is responsible for the death of beta-cells during the early stages of type II diabetes. It has been hypothesized that transient membrane-bound alpha-helical structures of human IAPP are precursors to the formation of these amyloid deposits. On the other hand, rat IAPP forms transient alpha-helical structures but does not progress further to form amyloid fibrils. To understand the nature of this intermediate state and the difference in toxicity between the rat and human versions of IAPP, we have solved the high-resolution structure of rat IAPP in the membrane-mimicking detergent micelles composed of dodecylphosphocholine. The structure is characterized by a helical region spanning the residues A5 to S23 and a disordered C-terminus. A distortion in the helix is seen at R18 and S19 that may be involved in receptor binding. Paramagnetic quenching NMR experiments indicate that rat IAPP is bound on the surface of the micelle, in agreement with other nontoxic forms of IAPP. A comparison to the detergent-bound structures of other IAPP variants indicates that the N-terminal region may play a crucial role in the self-association and toxicity of IAPP by controlling access to the putative dimerization interface on the hydrophobic face of the amphipathic helix.

[1]  A. Gronenborn,et al.  Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. , 1988, Protein engineering.

[2]  C. Dobson,et al.  On the role of the C-terminus of alpha-calcitonin-gene-related peptide (alpha CGRP). The structure of des-phenylalaninamide37-alpha CGRP and its interaction with the CGRP receptor. , 1993, The Biochemical journal.

[3]  S. Jayasinghe,et al.  Lipid membranes modulate the structure of islet amyloid polypeptide. , 2005, Biochemistry.

[4]  C. Baldauf,et al.  Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor. , 2006, Journal of medicinal chemistry.

[5]  U. Aebi,et al.  Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. , 2004, Journal of molecular biology.

[6]  Maarten F. M. Engel,et al.  Islet amyloid polypeptide‐induced membrane leakage involves uptake of lipids by forming amyloid fibers , 2004, FEBS letters.

[7]  Andrew D. Miranker,et al.  Direct detection of transient α‐helical states in islet amyloid polypeptide , 2007 .

[8]  Maarten F. M. Engel,et al.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.

[9]  T. Hauß,et al.  Neutron diffraction reveals sequence‐specific membrane insertion of pre‐fibrillar islet amyloid polypeptide and inhibition by rifampicin , 2005, FEBS letters.

[10]  J. Brender,et al.  Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. , 2008, Journal of the American Chemical Society.

[11]  E. Roberts,et al.  Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains. , 2001, Biochemistry.

[12]  Ad Bax,et al.  Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.

[13]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[14]  T. Rink,et al.  8–37h‐CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo , 1991, FEBS letters.

[15]  A. Ramamoorthy,et al.  Conformational studies of human islet amyloid peptide using molecular dynamics and simulated annealing methods. , 1998, Biopolymers.

[16]  Ueli Aebi,et al.  The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. , 2005, Journal of molecular biology.

[17]  D. Craik,et al.  Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.

[18]  J. Brender,et al.  Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. , 2007, Biochimica et biophysica acta.

[19]  P. Amodeo,et al.  Solution structure of human calcitonin in membrane‐mimetic environment: The role of the amphipathic helix , 1998, Proteins.

[20]  J. Danielsson,et al.  Positioning of the Alzheimer Aβ(1–40) peptide in SDS micelles using NMR and paramagnetic probes , 2007, Journal of biomolecular NMR.

[21]  A. Miranker,et al.  Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. , 2006, Biochemistry.

[22]  Richard Leapman,et al.  Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.

[23]  C. Betsholtz,et al.  Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A T Brünger,et al.  Torsion-angle molecular dynamics as a new efficient tool for NMR structure calculation. , 1997, Journal of magnetic resonance.

[25]  Hai Lin,et al.  Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  V. Picciarelli,et al.  Channel formation by salmon and human calcitonin in black lipid membranes. , 2001, Biophysical journal.

[27]  A. Miranker,et al.  Phospholipid catalysis of diabetic amyloid assembly. , 2004, Journal of molecular biology.

[28]  P. M. Doyle,et al.  Conformational restraints revealing bioactive β‐bend structures for hα CGRP8–37 at the CGRP2 receptor of the rat prostatic vas deferens , 1999 .

[29]  J. Vederas,et al.  Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. , 2005, Chemistry and physics of lipids.

[30]  S. Jayasinghe,et al.  Structure of α-Helical Membrane-bound Human Islet Amyloid Polypeptide and Its Implications for Membrane-mediated Misfolding* , 2008, Journal of Biological Chemistry.

[31]  Gianluigi Veglia,et al.  Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. , 2008, Biochemistry.

[32]  A. Bax,et al.  Comparison of Structure and Dynamics of Micelle-bound Human α-Synuclein and Parkinson Disease Variants* , 2005, Journal of Biological Chemistry.

[33]  D. Raleigh,et al.  Effects of sequential proline substitutions on amyloid formation by human amylin20-29. , 1999, Biochemistry.

[34]  C. Dobson,et al.  Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M Morfis,et al.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. , 1999, Molecular pharmacology.

[36]  Gerard J A Kroon,et al.  Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. , 2008, Biochemistry.

[37]  V. Picciarelli,et al.  Effect of pH-variation on insertion and ion channel formation of human calcitonin into planar lipid bilayers. , 2006, Frontiers in bioscience : a journal and virtual library.

[38]  Bernhard Pfeiffer,et al.  Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. , 2005, Chemical reviews.

[39]  J. Pettegrew,et al.  Alzheimer’s Disease: Soluble Oligomeric Aβ(1–40) Peptide in Membrane Mimic Environment from Solution NMR and Circular Dichroism Studies , 2004, Neurochemical Research.

[40]  A. Bax,et al.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology , 1999, Journal of biomolecular NMR.

[41]  S. Jayasinghe,et al.  Membrane interaction of islet amyloid polypeptide. , 2007, Biochimica et biophysica acta.

[42]  A. Couvineau,et al.  Class-B GPCR activation: is ligand helix-capping the key? , 2008, Trends in biochemical sciences.

[43]  Kevin Hartman,et al.  A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. , 2008, Biochemistry.

[44]  E. Gazit,et al.  The minimal amyloid‐forming fragment of the islet amyloid polypeptide is a glycolipid‐binding domain , 2006, The FEBS journal.

[45]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[46]  C. Aisenbrey,et al.  How is protein aggregation in amyloidogenic diseases modulated by biological membranes? , 2008, European Biophysics Journal.

[47]  Dong-Kuk Lee,et al.  Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. , 2002, Biophysical journal.

[48]  A. Pastore,et al.  Dynamic properties of salmon calcitonin bound to sodium dodecyl sulfate micelles: A restrained molecular dynamics study from NMR data , 1992, Journal of biomolecular NMR.

[49]  D. Raleigh,et al.  Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP? , 2006, Journal of molecular biology.

[50]  A. Miranker,et al.  Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide. , 2008, Protein engineering, design & selection : PEDS.

[51]  Laura Zanetti Polzi,et al.  Calcitonin forms oligomeric pore-like structures in lipid membranes. , 2006, Biophysical journal.

[52]  A. Alexandrescu,et al.  Dynamic α-Helix Structure of Micelle-bound Human Amylin* , 2009, Journal of Biological Chemistry.

[53]  R. Epand,et al.  Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs. , 1990, Endocrinology.

[54]  A. Pastore,et al.  Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations. , 1991, Biochemistry.

[55]  D. Raleigh,et al.  A role for helical intermediates in amyloid formation by natively unfolded polypeptides? , 2009, Physical biology.

[56]  S. Wimalawansa,et al.  Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. , 1997, Critical reviews in neurobiology.

[57]  A. Kapurniotu,et al.  Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt. , 2002, European journal of biochemistry.

[58]  J. W. Taylor,et al.  Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues. , 1999, European journal of biochemistry.

[59]  U. Aebi,et al.  Full-length rat amylin forms fibrils following substitution of single residues from human amylin. , 2003, Journal of molecular biology.

[60]  E. Rizzarelli,et al.  DSC study of the interaction of the prion peptide PrP106–126 with artificial membranes , 2001 .

[61]  A. Magrì,et al.  Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives. , 2007, Chemistry.

[62]  D. van der Spoel,et al.  Molecular dynamics simulations of dodecylphosphocholine micelles at three different aggregate sizes: Micellar structure and chain relaxation , 2000 .

[63]  E. Scharrer,et al.  Amylin receptors mediate the anorectic action of salmon calcitonin (sCT) , 2000, Peptides.

[64]  P. Kinnunen,et al.  Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers. , 2008, Journal of molecular biology.

[65]  S. Lenzen,et al.  Lipid composition of glucose-stimulated pancreatic islets and insulin-secreting tumor cells , 1994, Lipids.

[66]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[67]  G. Veglia,et al.  Conformational preferences of the amylin nucleation site in SDS micelles: An NMR study , 2003, Biopolymers.

[68]  Maarten F. M. Engel,et al.  Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in β-Cell Death in Type 2 Diabetes Mellitus , 2008, Experimental diabetes research.

[69]  D. Milardi,et al.  Calcium-activated membrane interaction of the islet amyloid polypeptide: implications in the pathogenesis of type II diabetes mellitus. , 2008, Archives of biochemistry and biophysics.

[70]  David Eisenberg,et al.  Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.

[71]  Michael F. Brown,et al.  Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. , 2004, Biochemistry.